SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Cohance Lifesciences to invest $18 million across NJ Bio and Aruka Bio

Cohance Lifesciences plans to invest a combined $18 million in NJ Bio and Aruka Bio as it deepens its antibody-drug conjugates, or ADCs, push. The company will invest $13 million to increase its ownership of NJ Bio.

COHANCE

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories